Bone Densitometer Market by Type, Application, End-User

List of Tables

[191 Pages Report] The Bone Densitometer Market size was estimated at USD 322.87 million in 2023 and expected to reach USD 338.07 million in 2024, at a CAGR 4.79% to reach USD 448.07 million by 2030.

The bone densitometer comprises devices that primarily help assess bone density, diagnose osteoporosis, and evaluate the risk of fracture in individuals. These devices utilize various technologies such as Dual-Energy X-ray Absorptiometry (DXA), ultrasound, and quantitative computed tomography (QCT) to quantify bone mineral content and accurately assess bone health. An aging global population, increasing prevalence of osteoporosis, and rising awareness about early diagnosis and prevention measures among patients have increased the need for bone densitometers worldwide. However, the high costs of products coupled with errors associated with the results of bone densitometers limit product penetration. In addition, the strict government approval procedures to approve newly developed product portfolios negatively impact the availability of bone densitometers. The significant investments by the market players in research and development and the emergence of advanced bone densitometers are expected to create growth opportunities for the bone densitometer market in the coming years.

KEY MARKET STATISTICS
Base Year [2023]	USD 322.87 million
Estimated Year [2024]	USD 338.07 million
Forecast Year [2030]	USD 448.07 million
CAGR (%)	4.79%

Regional Insights

The bone densitometer market is witnessing growth across the Americas, particularly in developed markets such as the United States and Canada, owing to high demand for bone densitometers due to increasing awareness about bone health and greater incidence of orthopedic conditions. Further, advances in research have also played a significant role in driving market growth. In the EU region, trends regarding osteoporosis diagnosis and care management initiatives have driven adoption rates for bone densitometer devices. Additionally, public health programs promoting preventative care measures contribute significantly to market growth in EU countries. However, with strategic investments in healthcare infrastructure and increasing focus on preventive care across the Middle East and Africa region, market growth is expected to grow in the coming years. The Asia-Pacific region is experiencing growth in the bone densitometer market, driven mainly by China, Japan, and India. These countries have a large aging population at risk for developing osteoporosis and other related conditions. The growing demand for portable devices such as DXA systems has resulted from increased awareness campaigns regarding bone health issues. Furthermore, government initiatives promoting research into diagnostic technologies have significantly impacted this market's expansion within this region.

Market Insights

Market Dynamics

The market dynamics represent an ever-changing landscape of the Bone Densitometer Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

Market Drivers
- Increasing prevalence of osteoporosis along with rising geriatric population
- Advancements in DXA scanners resulting in quicker and more accurate diagnosis
- Rising use of densitometer due to growing incidents of fragility fracture

Market Restraints
- High cost associated with bone densitometers and imitated bone density testing

Market Opportunities
- Increasing investments to improve the existing healthcare infrastructure
- Ongoing product advancements for enhanced accuracy, precision, and safety

Market Challenges
- Technical limitations of bone densitometers coupled with stringent regulatory approval processes

Market Segmentation Analysis
- Type: Proliferating usage of Dual-energy X-ray absorptiometry for a detailed analysis of bones
- End-User: Proliferation of bone densitometer in imaging centers

Market Disruption Analysis
Porter's Five Forces Analysis
Value Chain & Critical Path Analysis
Pricing Analysis
Technology Analysis
Patent Analysis
Trade Analysis
Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Bone Densitometer Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Bone Densitometer Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Fujitsu and iSurgery launched a bone health promotion project in Japan with Jikei University School of Medicine aiming for the early detection of osteoporosis

Fujitsu Limited and iSurgery Co., Ltd. are collaborating with the Department of Orthopaedic Surgery at Jikei University School of Medicine to conduct a field trial of their "bone health promotion project" from October 2023 to March 2025. This project aims to focus on employee bone health during examinations by utilizing chest radiographs in a novel way. The project group will utilize iSurgery's AI medical device, Chest Bone Indicator, to assess bone health from chest radiographs and inform staff members of their examination results. [Published On: 2023-09-26]

AFFIDEA Expands In Italy Through The Acquisition Of Istituto Radiologico Gandini

Affidea, a provider of diagnostic imaging, out-of-hospital, and cancer care services, has recently acquired Istituto Radiologico Gandini in Biella, Piedmont. Istituto Radiologico Gandini is renowned for its advanced diagnostic imaging services, particularly radiology and senology. The medical facility offers various innovative diagnostic technologies, including MRI, mammography, Bone Densitometry, Doppler ultrasound, and comprehensive breast check-ups. This acquisition further strengthens Affidea's commitment to delivering patients high-quality and cutting-edge diagnostic services. [Published On: 2023-05-05]

Medimaps Group Announces Partnership With OsteoSys to Bring Trabecular Bone Score to Korea's Leading Bone Densitometry Platform

MEDIMAPS GROUP, a Swiss-global med-tech company specializing in image processing software for bone health assessment, has made their Trabecular Bone Score (TBS iNsight) available on OsteoSys Co. Ltd's diagnostic platforms. OsteoSys, the Bone Mineral Densitometer brand in Korea and supplier of DXA scanning equipment worldwide, now offers TBS iNsight on their high-end DXA scanning product, Primus Whole Body DXA. This partnership aims to expand access to Medimaps' innovative technology to clinicians worldwide, including countries throughout Southeast Asia, Europe, and South America. [Published On: 2022-11-14]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Bone Densitometer Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Bone Densitometer Market, highlighting leading vendors and their innovative profiles. These include Anjue Medical Equipment, BeamMed, Ltd., Diagnostic Medical Systems Group, Echolight S.P.A, Eurotec Systems S.r.l, FURUNO Electric Co., Ltd., GE HealthCare Technologies, Inc., Hologic, Inc., Intermedical Co.,Ltd., KWIPPED, Inc., L'acn L'accessorio Nucleare S.R.L, M-cast Inc., Medilink International Ltd., Medonica Co., Ltd., mpall Co., Ltd., Nanjing Kejin Industrial Co., Ltd., Nanoomtech Co., Ltd., Oscare Medical Oy, Osteosys Corporation, Scanflex Healthcare AB, Shenzhen XRAY Electric Co., Ltd., Swissray International, Inc., Trivitron Healthcare, Xianyang Kanrota Digital Ultrasound System, Co., Ltd., and YOZMA BMTech Co., Ltd..

Market Segmentation & Coverage

This research report categorizes the Bone Densitometer Market to forecast the revenues and analyze trends in each of the following sub-markets:

Type
- Axial Bone Densitometry
- Dual-energy X-Ray Absorptiometry (DEXA)
- Peripheral Bone Densitometry
- Quantitative Computed Tomography (QCT)
- Quantitative Ultrasound (QUS)
- Radiographic Absorptiometry (RA)

Application
- Body Composition Measurement Diagnosis
- Chronic Kidney Diseases Diagnosis
- Cystic Fibrosis Diagnosis
- Osteoporosis & Osteopenia Diagnosis
- Rheumatoid Arthritis Diagnosis

End-User
- Diagnostic & Imaging Centers
- Hospitals & Specialty Clinics

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam

Europe, Middle East & Africa
- Denmark
- Egypt
- Finland
- France
- Germany
- Israel
- Italy
- Netherlands
- Nigeria
- Norway
- Poland
- Qatar
- Russia
- Saudi Arabia
- South Africa
- Spain
- Sweden
- Switzerland
- Turkey
- United Arab Emirates
- United Kingdom

Product Code: MRR-3D2FD205D8B8

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

5.1. Market Dynamics
- 5.1.1. Drivers
  - 5.1.1.1. Increasing prevalence of osteoporosis along with rising geriatric population
  - 5.1.1.2. Advancements in DXA scanners resulting in quicker and more accurate diagnosis
  - 5.1.1.3. Rising use of densitometer due to growing incidents of fragility fracture
- 5.1.2. Restraints
  - 5.1.2.1. High cost associated with bone densitometers and imitated bone density testing
- 5.1.3. Opportunities
  - 5.1.3.1. Increasing investments to improve the existing healthcare infrastructure
  - 5.1.3.2. Ongoing product advancements for enhanced accuracy, precision, and safety
- 5.1.4. Challenges
  - 5.1.4.1. Technical limitations of bone densitometers coupled with stringent regulatory approval processes
5.2. Market Segmentation Analysis
- 5.2.1. Type: Proliferating usage of Dual-energy X-ray absorptiometry for a detailed analysis of bones
- 5.2.2. End-User: Proliferation of bone densitometer in imaging centers
5.3. Market Disruption Analysis
5.4. Porter's Five Forces Analysis
- 5.4.1. Threat of New Entrants
- 5.4.2. Threat of Substitutes
- 5.4.3. Bargaining Power of Customers
- 5.4.4. Bargaining Power of Suppliers
- 5.4.5. Industry Rivalry
5.5. Value Chain & Critical Path Analysis
5.6. Pricing Analysis
5.7. Technology Analysis
5.8. Patent Analysis
5.9. Trade Analysis
5.10. Regulatory Framework Analysis

6. Bone Densitometer Market, by Type

6.1. Introduction
6.2. Axial Bone Densitometry
6.3. Dual-energy X-Ray Absorptiometry (DEXA)
6.4. Peripheral Bone Densitometry
6.5. Quantitative Computed Tomography (QCT)
6.6. Quantitative Ultrasound (QUS)
6.7. Radiographic Absorptiometry (RA)

7. Bone Densitometer Market, by Application

7.1. Introduction
7.2. Body Composition Measurement Diagnosis
7.3. Chronic Kidney Diseases Diagnosis
7.4. Cystic Fibrosis Diagnosis
7.5. Osteoporosis & Osteopenia Diagnosis
7.6. Rheumatoid Arthritis Diagnosis

8. Bone Densitometer Market, by End-User

8.1. Introduction
8.2. Diagnostic & Imaging Centers
8.3. Hospitals & Specialty Clinics

9. Americas Bone Densitometer Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Bone Densitometer Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Bone Densitometer Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. Market Share Analysis, 2023
12.2. FPNV Positioning Matrix, 2023
12.3. Competitive Scenario Analysis
- 12.3.1. Fujitsu and iSurgery launched a bone health promotion project in Japan with Jikei University School of Medicine aiming for the early detection of osteoporosis
- 12.3.2. AFFIDEA Expands In Italy Through The Acquisition Of Istituto Radiologico Gandini
- 12.3.3. Medimaps Group Announces Partnership With OsteoSys to Bring Trabecular Bone Score to Korea's Leading Bone Densitometry Platform
12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

13.1. Key Company Profiles
13.2. Key Product Portfolio